Immix Biopharma, Inc.
IMMX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17,682 | $17,510 | $13,437 | $17,644 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1,974 | $1,172 | $256 | $26 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $542 | $1,106 | $1,205 | $516 |
| Total Curr. Assets | $20,198 | $19,788 | $14,898 | $18,186 |
| Property Plant & Equip (Net) | $2,730 | $50 | $4 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $20 | $87 | $7 | $0 |
| Total NC Assets | $2,750 | $137 | $10 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $22,948 | $19,925 | $14,908 | $18,192 |
| Liabilities | – | – | – | – |
| Payables | $5,388 | $1,433 | $143 | $143 |
| Short-Term Debt | $65 | $0 | $0 | $50 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,233 | $2,289 | $1,130 | $9 |
| Total Curr. Liab. | $8,687 | $3,722 | $1,273 | $202 |
| LT Debt | $1,010 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $475 | $0 |
| Total NC Liab. | $1,010 | $0 | $475 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,075 | $0 | $0 | $0 |
| Total Liabilities | $9,697 | $3,722 | $1,748 | $202 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $2 | $1 | $1 |
| Retained Earnings | -$75,025 | -$53,411 | -$37,985 | -$29,756 |
| AOCI | -$1 | $135 | $87 | $125 |
| Other Equity | $88,274 | $69,680 | $51,057 | $47,619 |
| Total Equity | $13,251 | $16,405 | $13,160 | $17,990 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | -$202 | $0 | $0 |
| Total Liab. & Tot. Equity | $22,948 | $19,925 | $14,908 | $18,192 |
| Net Debt | -$16,607 | -$17,510 | -$13,437 | -$17,594 |